These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21077345)

  • 1. [Effects of combination therapy with losartan/hydrochlorothiazide on the relationships between base blood pressure, autonomic function, and health-related QOL].
    Okano Y; Toya Y; Azuma K; Yabana M; Tamura K; Umemura S
    Nihon Jinzo Gakkai Shi; 2010; 52(7):939-44. PubMed ID: 21077345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL.
    Okano Y; Tamura K; Kuji T; Masuda S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2009 May; 31(3):250-8. PubMed ID: 19387901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension].
    Minami J; Ishimitsu T; Matsuoka H
    Nihon Jinzo Gakkai Shi; 2005; 47(8):864-9. PubMed ID: 16408430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients.
    Ohshiro K; Sakima A; Nakada S; Kohagura K; Yamazato M; Tana T; Ohya Y
    Clin Exp Hypertens; 2011; 33(8):565-70. PubMed ID: 21958001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin II receptor blockers on the relationships between ambulatory blood pressure and anti-hypertensive effects, autonomic function, and health-related quality of life.
    Okano Y; Tamura K; Masuda S; Ozawa M; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2009 Nov; 31(8):680-9. PubMed ID: 20001460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between base blood pressure during sleep and health-related quality of life in healthy adults.
    Okano Y; Tochikubo O; Umemura S
    J Hum Hypertens; 2007 Feb; 21(2):135-40. PubMed ID: 17096005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats.
    Nobre F; da Silva CA; Coelho EB; Salgado HC; Fazan R
    Am J Hypertens; 2006 Oct; 19(10):1079-83. PubMed ID: 17027832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
    Radchenko GD; Sirenko YM; Kushnir SM; Torbas OO; Dobrokhod AS
    Vasc Health Risk Manag; 2013; 9():535-49. PubMed ID: 24109189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
    Fukutomi M; Hoshide S; Eguchi K; Watanabe T; Kario K
    Am J Hypertens; 2013 Jun; 26(6):784-92. PubMed ID: 23446957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study.
    Koren-Michowitz M; Dishy V; Zaidenstein R; Yona O; Berman S; Weissgarten J; Golik A
    Am J Hypertens; 2005 Mar; 18(3):358-63. PubMed ID: 15797654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of base heart rate in autonomic nervous function, blood pressure and health-related QOL.
    Okano Y; Hirawa N; Matsushita K; Tamura K; Kihara M; Toya Y; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2005; 27(2-3):169-78. PubMed ID: 15835379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours].
    Förster A; Smolka W; Jung C; Bestehorn K
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():111-8. PubMed ID: 17955788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching therapy from variable-dose multiple pill to fixed-dose single-pill combinations of angiotensin II receptor blockers and thiazides for hypertension.
    Sakima A; Ohshiro K; Nakada S; Yamazato M; Kohagura K; Nakamoto M; Tana T; Ohya Y
    Clin Exp Hypertens; 2011; 33(5):309-15. PubMed ID: 21649528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.